Heider R, Behrns K E
Department of Surgery, University of North Carolina at Chapel Hill, 27599-7210, USA.
Pancreas. 2001 Jul;23(1):20-5. doi: 10.1097/00006676-200107000-00003.
Pancreatic pseudocysts are a common finding in acute and chronic pancreatitis, but most are small and uncomplicated, and do not require treatment. Pseudocysts with splenic parenchymal involvement are uncommon but have the potential for massive hemorrhage. Data on the clinical presentation and optimal treatment of this unusual complication of pseudocysts are lacking. The purpose of this review was to identify the clinical features of pancreatic pseudocysts complicated by splenic parenchymal involvement and to determine the outcome with nonoperative and operative therapy.
A retrospective review of the medical records of all patients with pancreatic pseudocysts from December 1984 to January 1999 revealed 238 patients, of whom 14 (6%) had splenic parenchymal involvement. These medical records were reviewed in detail and all pertinent radiographs were reviewed by the authors to confirm splenic parenchymal involvement by a pancreatic pseudocyst.
Initial treatment included observation (n = 2), percutaneous drainage (n = 8), and surgery (n = 4). Of the eight patients treated by percutaneous drainage, one died, three required repeated percutaneous drainage, and three required surgical intervention. None of the patients treated primarily by surgery required additional therapy for the pseudocyst. Overall, 11 patients had complications of the primary therapy, and 25% of patients treated by surgery had significant hemorrhage. Complications included infection (n = 5), pseudocyst persistence (n = 4), bleeding (n = 2), multisystem organ failure (n = 2), gastric outlet obstruction (n = 1), and splenic rupture (n = 2).
Pancreatic pseudocysts complicated by splenic parenchymal involvement may have life-threatening clinical presentations and respond poorly to percutaneous drainage. Distal pancreatectomy and splenectomy are effective, but the complication rate is high.
胰腺假性囊肿在急性和慢性胰腺炎中很常见,但大多数较小且不复杂,无需治疗。累及脾实质的假性囊肿并不常见,但有发生大出血的可能。关于这种假性囊肿不寻常并发症的临床表现和最佳治疗的数据尚缺乏。本综述的目的是确定合并脾实质受累的胰腺假性囊肿的临床特征,并确定非手术和手术治疗的结果。
对1984年12月至1999年1月所有胰腺假性囊肿患者的病历进行回顾性研究,共发现238例患者,其中14例(6%)累及脾实质。作者详细回顾了这些病历,并复查了所有相关的X线片,以确认胰腺假性囊肿累及脾实质。
初始治疗包括观察(2例)、经皮引流(8例)和手术(4例)。在8例接受经皮引流治疗的患者中,1例死亡,3例需要重复经皮引流,3例需要手术干预。所有主要接受手术治疗的患者均无需对假性囊肿进行额外治疗。总体而言,11例患者出现了初始治疗的并发症,手术治疗的患者中有25%发生了严重出血。并发症包括感染(5例)、假性囊肿持续存在(4例)、出血(2例)、多系统器官衰竭(2例)、胃出口梗阻(1例)和脾破裂(2例)。
合并脾实质受累的胰腺假性囊肿可能有危及生命的临床表现,对经皮引流反应不佳。胰体尾切除术和脾切除术有效,但并发症发生率高。